278 related articles for article (PubMed ID: 28665921)
1. Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice.
Jeon YJ; Sah SK; Yang HS; Lee JH; Shin J; Kim TY
Exp Mol Med; 2017 Jun; 49(6):e349. PubMed ID: 28665921
[TBL] [Abstract][Full Text] [Related]
2. Rhododendrin ameliorates skin inflammation through inhibition of NF-κB, MAPK, and PI3K/Akt signaling.
Jeon YJ; Kim BH; Kim S; Oh I; Lee S; Shin J; Kim TY
Eur J Pharmacol; 2013 Aug; 714(1-3):7-14. PubMed ID: 23764465
[TBL] [Abstract][Full Text] [Related]
3. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
4. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
[TBL] [Abstract][Full Text] [Related]
5. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
[TBL] [Abstract][Full Text] [Related]
6. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
8. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468
[TBL] [Abstract][Full Text] [Related]
9. Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.
Sah SK; Park KH; Yun CO; Kang KS; Kim TY
Antioxid Redox Signal; 2016 Feb; 24(5):233-48. PubMed ID: 26462411
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y
Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
12. BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis.
Irrera N; Vaccaro M; Bitto A; Pallio G; Pizzino G; Lentini M; Arcoraci V; Minutoli L; Scuruchi M; Cutroneo G; Anastasi GP; Ettari R; Squadrito F; Altavilla D
Clin Sci (Lond); 2017 Mar; 131(6):487-498. PubMed ID: 28096316
[TBL] [Abstract][Full Text] [Related]
13. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
14. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L
Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203
[TBL] [Abstract][Full Text] [Related]
15. A PPARδ-selective antagonist ameliorates IMQ-induced psoriasis-like inflammation in mice.
Wang X; Hao Y; Wang X; Wang L; Chen Y; Sun J; Hu J
Int Immunopharmacol; 2016 Nov; 40():73-78. PubMed ID: 27584056
[TBL] [Abstract][Full Text] [Related]
16. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways.
Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM
Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480
[TBL] [Abstract][Full Text] [Related]
17. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N
Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402
[TBL] [Abstract][Full Text] [Related]
18. Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression.
Han L; Sun J; Lu CJ; Zhao RZ; Lu Y; Lin HJ; Wei JA
Int Immunopharmacol; 2017 Mar; 44():226-233. PubMed ID: 28129604
[TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines.
Wu Y; Chen X; Ge X; Xia H; Wang Y; Su S; Li W; Yang T; Wei M; Zhang H; Gou L; Li J; Jiang X; Yang J
J Mol Med (Berl); 2016 Feb; 94(2):195-206. PubMed ID: 26383911
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
Sun J; Zhao Y; Hu J
PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]